Influence of Intramuscular Nerve Growth Factor Injection on the Response Properties of Rat Masseter Muscle Afferent Fibers

Aims: To investigate whether local administration of nerve growth factor (NGF) decreases the mechanical threshold (MT) of putative nociceptive masseter afferent fibers as part of its mechanism of mechanical sensitization. Methods: Electrophysiologic recordings were made from masseter afferents and a randomized, blinded approach was used to test the effects of intramuscular injection of NGF (2.5 or 25 µg/mL) into the rat masseter muscle on the MT of masseter afferents (n = 65) and plasma protein extravasation. Results: The plasma protein extravasation data and electrophysio-logical recordings indicated that rat NGF injection was not inflammatory and did not evoke afferent discharge or induce mechanical sensitization (as reflected in a decreased MT) in mas-seter afferents in either male or female rats. To investigate whether the lack of effect of NGF injection might be due to differences between human and rat NGF, additional experiments with human NGF injection (25 µg/mL) were undertaken. Intramuscular injec-tion of human NGF into the rat masseter muscle also failed to evoke afferent discharges; however, it did decrease the MT of mas-seter afferent fibers. Conclusion: The finding that neither rat nor human NGF excited putative nociceptive masseter afferent fibers is consistent with a previous report that intramuscular NGF injec-tions are not acutely painful in human subjects. The ability of human NGF injection into the rat masseter muscle to induce affer-ent mechanical sensitization suggests that this experimental approach may be useful for the study of peripheral mechanisms of myofascial pain and tenderness associated with temporomandibu-lar disorders.

afferent fibers; masseter muscle; muscle pain; nerve growth fibers; temporomandibular disorders

1. LeResche L. Epidemiology of orofacial pain. In: Lund JP, Lavigne GJ, Dubner R, Sessle BJ (eds). Orofacial Pain: From Basic Science to Clinical Management. Chicago: Quintessence, 2001:15–26.

2. McNeill C, Dubner R. What is pain and how do we classify orofacial pain? In: Lund JP, Lavigne GJ, Dubner R, Sessle BJ (eds). Orofacial Pain: From Basic Science to Clinical Management. Chicago: Quintessence, 2001:3–14.

3. Dworkin SF, LeResche L. Research Diagnostic Criteria for Temporomandibular Disorders: Review, criteria, examinations and specifications, critique. J Craniomandib Disord 1992;6:301–355.

4. Nekora-Azak A. Temporomandibular disorders in relation to female reproductive hormones: A literature review. J Prosthet Dent 2004;91:491–493.

5. LeResche L, Saunders K, Von Korff MR, Barlow W, Dworkin SF. Use of exogenous hormones and risk of tem-poromandibular disorder pain. Pain 1997;69:153–160.

6. LeResche L, Mancl L, Sherman JJ, Gandara B, Dworkin SF. Changes in temporomandibular pain and other symptoms across the menstrual cycle. Pain 2003;106:253–261.

7. Isselee H, De Laat A, De Mot B, Lysens R. Pressure-pain threshold variation in temporomandibular disorder myalgia over the course of the menstrual cycle. J Orofac Pain 2002;16:105–117.

8. Stohler CS. Masticatory myalgias. Emphasis on the nerve growth factor-estrogen link. Pain Forum 1997;6:176–180.

9. Svensson P, Cairns BE, Wang K, Arendt-Nielsen L. Injection of nerve growth factor into human masseter muscle evokes long lasting mechanical allodynia and hyperalgesia. Pain 2003;104:241–247.

10. Chao MV. Neurotrophins and their receptors: A convergence point for many signaling pathways. Nat Rev Neurosci 2003;4:299–309.

11. Dmitrieva N, McMahon SB. Sensitisation of visceral afferents by nerve growth factor in the adult rat. Pain 1996;66:87–97.

12. Djouhri L, Dawbarn D, Robertson A, Newton R, Lawson SN. Time course and nerve growth factor dependence of inflammation-induced alterations in electrophysiological membrane properties in nociceptive primary afferent neurons. J Neurosci 2001;21:8722–8733.

13. Rueff A, Dawson AJ, Mendell LM. Characteristics of nerve growth factor induced hyperalgesia in adult rats: Dependence on enhanced bradykinin-1 receptor activity but not neurokinin-1 receptor activation. Pain 1996; 66:359–372.

14. Rueff A, Mendell LM. Nerve growth factor and NT-5 induce increased thermal sensitivity of cutaneous nociceptors in vitro. J Neurophysiol 1996;76:3593–3596.

15. Thompson SWN, Dray A, McCarson KE, Krause JE, Urban L. Nerve growth factor induces mechanical allodynia associated with novel A fibre-evoked spinal reflex activity and enhanced neurokinin-1 receptor activation in the rat. Pain 1995;62:219–231.

16. Lewin GR, Ritter AM, Mendell LM. Nerve growth factor-induced hyperalgesia in the neonatal and adult rat. J Neurosci 1993;13:2136–2148.

17. Lewin GR, Rueff A, Mendell LM. Peripheral and central mechanisms of NGF-induced hyperalgesia. Eur J Neurosci 1994;6:1903–1912.

18. Cairns BE, Gambarota G, Svensson P, Arendt-Nielsen L, Berde CB. Glutamate-induced sensitization of rat masseter muscle fibers. Neuroscience 2002;109:389–399.

19. Arvidsson J, Raappana P. An HRP study of the central projections from primary sensory neurons innervating the rat masseter muscle. Brain Res 1989;480:111–118.

20. Capra NF, Wax TD. Distribution and central projections of primary afferent neurons that innervated the masseter muscle and mandibular periodontium: A double-label study. J Comp Neurol 1989; 279:341–352.

21. Shigenaga Y, Sera M, Nishimori T, et al. The central pro-jection of masticatory afferent fibers to the trigeminal sensory nuclear complex and upper cervical spinal cord. J Comp Neurol 1988;268:489–507.

22. Fiorentino PM, Cairns BE, Hu JW. Development of inflammation after application of mustard oil or glutamate to the rat temporomandibular joint. Arch Oral Biol 1999;44:27–32.

23. Svensson P, Cairns BE, Wang K, et al. Glutamate-evoked pain and mechanical allodynia in the human masseter muscle. Pain 2003;101:221–227.

24. Andreev NY, Dimitrieva N, Koltzenburg M, McMahon SB. Peripheral administration of nerve growth factor in the adult rat produces a thermal hyperalgesia that requires the presence of sympathetic post-ganglionic neurons. Pain 1995;63:109–115.

25. Chuang H, Prescott ED, Kong H, et al. Bradykinin and nerve growth factor release the capsaicin receptor from PtdIns(4,5)P2-mediated inhibition. Nature Rev 2001; 411:957–962.

26. Cairns BE, Svensson P, Wang K, et al. Activation of peripheral NMDA receptors contributes to human pain and rat afferent discharges evoked by injection of glutamate into the masseter muscle. J Neurophysiol 2003; 90:2098–2105.

27. Malik-Hall M, Dina OA, Levine JD. Primary afferent nociceptor mechanisms mediating NGF-induced mechanical hyperalgesia. Eur J Neurosci 2005;21:3387–3394.

28. Cain DM, Khasabov SG, Simone DA. Response properties of mechanoreceptors and nociceptors in mouse glabrous skin: An in vivo study. J Neurophysiol 2001;85:1561–1574.

29. Du J, Koltzenburg M, Carlton SM. Glutamate-induced excitation and sensitization of nociceptors in rat glabrous skin. Pain 2001;89:187–198.

30. Djouhri L, Lawson SN. Increased conduction velocity of nociceptive primary afferent neurons during unilateral hindlimb inflammation in the anaesthetised guineapig. Neuroscience 2001;102:669–679.

31. Ge W, Khalsa PS. Encoding of compressive stress during indentation by group III and IV muscle mechano-nociceptors in rat gracilis muscle. J Neurophysiol 2003;89:785–792.